Peter Mallmann

8.9k total citations
278 papers, 4.7k citations indexed

About

Peter Mallmann is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Peter Mallmann has authored 278 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Reproductive Medicine, 76 papers in Public Health, Environmental and Occupational Health and 70 papers in Oncology. Recurrent topics in Peter Mallmann's work include Reproductive Biology and Fertility (54 papers), Endometrial and Cervical Cancer Treatments (47 papers) and Ovarian cancer diagnosis and treatment (30 papers). Peter Mallmann is often cited by papers focused on Reproductive Biology and Fertility (54 papers), Endometrial and Cervical Cancer Treatments (47 papers) and Ovarian cancer diagnosis and treatment (30 papers). Peter Mallmann collaborates with scholars based in Germany, United States and Bulgaria. Peter Mallmann's co-authors include Evgenia Isachenko, Vladimir Isachenko, Gohar Rahimi, Christian M. Kurbacher, Frank Nawroth, G Rahimi, D. Krebs, Stefan Sauerland, Edmund Neugebauer and M. Nagelschmidt and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Peter Mallmann

259 papers receiving 4.6k citations

Peers

Countries citing papers authored by Peter Mallmann

Since Specialization

Citations

This map shows the geographic impact of Peter Mallmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Mallmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Mallmann more than expected).

Fields of papers citing papers by Peter Mallmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Mallmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Mallmann. The network helps show where Peter Mallmann may publish in the future.

Co-authorship network of co-authors of Peter Mallmann

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Mallmann. A scholar is included among the top collaborators of Peter Mallmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Mallmann. Peter Mallmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	RNA Transcripts in Human Ovarian Cells: Two-Time Cryopreservation Does Not Affect Developmental Potential 2023 ·International Journal of Molecular Sciences ·Yang Zhou, (unknown), Plamen Todorov, (unknown), Evgenia Isachenko, Gohar Rahimi, Peter Mallmann, Frank Nawroth, Vladimir Isachenko	6
2	Automatic Evaluation for Bioengineering of Human Artificial Ovary: A Model for Fertility Preservation for Prepubertal Female Patients with a Malignant Tumor 2022 ·International Journal of Molecular Sciences ·(unknown), (unknown), Evgenia Isachenko, Yang Zhou, Mengying Wang, Gohar Rahimi, (unknown), Peter Mallmann, Vladimir Isachenko	12
3	Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial 2022 ·Journal for ImmunoTherapy of Cancer ·Lukáš Rob, David Cibula, Paweł Knapp, Peter Mallmann, Jaroslav Klát, Luboš Minář, Pavel Bartoš, Josef Chovanec, (unknown), Marek Pluta, (unknown), Jiří Špaček, Bohuslav Melichar, (unknown), Jitka Fučíková, Tereza Hrnčiarová, Roman Korolkiewicz, (unknown), Jiřina Bartůňková, Radek Špíšek	31
4	Construction and cryopreservation of an artificial ovary in cancer patients as an element of cancer therapy and a promising approach to fertility restoration 2021 ·Human Fertility ·Jing Chen, Plamen Todorov, Evgenia Isachenko, Gohar Rahimi, Peter Mallmann, Vladimir Isachenko	18
5	Optimization of Follicle Isolation for Bioengineering of Human Artificial Ovary 2021 ·Biopreservation and Biobanking ·Jing Chen, Evgenia Isachenko, (unknown), Xinxin Du, Mengying Wang, Gohar Rahimi, Peter Mallmann, Vladimir Isachenko	3
6	High cryo-resistance of SARS-CoV-2 virus: Increased risk of re-contamination at transplantation of cryopreserved ovarian tissue after COVID-19 pandemic 2021 ·Cryobiology ·Vladimir Isachenko, Evgenia Isachenko, Peter Mallmann, Gohar Rahimi	2
7	New method of FACS analyzing and sorting of intact whole ovarian fragments (COPAS) after long time (24 h) cooling to 5 °C before cryopreservation 2021 ·Cell and Tissue Banking ·(unknown), Mahmoud Salama, Plamen Todorov, (unknown), Evgenia Isachenko, (unknown), Gohar Rahimi, Peter Mallmann, Г. Т. Сухих, Vladimir Isachenko	8
8	Aseptic Technology for Cryoprotectant‐Free Vitrification of Human Spermatozoa by Direct Dropping into Clean Liquid Air: Apoptosis, Necrosis, Motility, and Viability 2020 ·BioMed Research International ·(unknown), Evgenia Isachenko, Plamen Todorov, Gohar Rahimi, Peter Mallmann, Igor I. Katkov, Vladimir Isachenko	6
9	Increasing of malignancy of breast cancer cells after cryopreservation: molecular detection and activation of angiogenesis after CAM-xenotransplantation 2020 ·BMC Cancer ·Xinxin Du, Plamen Todorov, Evgenia Isachenko, Gohar Rahimi, Peter Mallmann, Yuanguang Meng, Vladimir Isachenko	5
10	Patient with ovarian insufficiency: baby born after anticancer therapy and re-transplantation of cryopreserved ovarian tissue 2020 ·Journal of Ovarian Research ·Vladimir Isachenko, Bernd Morgenstern, Plamen Todorov, Evgenia Isachenko, Peter Mallmann, Bettina Hanstein, Gohar Rahimi	9
11	Banking of human ovarian tissue potentially contaminated by cancer cells: experimental model for study of cryo-stability of these cells 2019 ·Cell and Tissue Banking ·Vladimir Isachenko, Xinxin Du, Evgenia Isachenko, Plamen Todorov, Peter Mallmann, (unknown), Gohar Rahimi	2
12	Cryoprotectant-free vitrification of spermatozoa: Fish as a model of human 2018 ·Andrologia ·Vladimir Isachenko, Raúl Sánchez, Gohar Rahimi, Peter Mallmann, Evgenia Isachenko, (unknown)	8
13	Technologies of cryoprotectant‐free vitrification of human spermatozoa: asepticity as criterion of effectiveness 2017 ·Andrology ·Vladimir Isachenko, G Rahimi, Peter Mallmann, Raúl Sánchez, Evgenia Isachenko	39
14	Use of the fluorescent dye tetramethylrhodamine methyl ester perchlorate for mitochondrial membrane potential assessment in human spermatozoa 2017 ·Andrologia ·Pamela Uribe, J. Villegas, (unknown), F. Treulen, Raúl Sánchez, Peter Mallmann, Vladimir Isachenko, G Rahimi, Evgenia Isachenko	28
15	STAT3/IRF1 Pathway Activation Sensitizes Cervical Cancer Cells to Chemotherapeutic Drugs 2016 ·Cancer Research ·Barbara Walch‐Rückheim, (unknown), (unknown), Claudia Wickenhauser, Lars Christian Horn, Lars Tharun, Reinhard Büttner, Peter Mallmann, Peter L. Stern, Yoo-Jin Kim, Rainer M. Bohle, Christian Rübe, (unknown), Ingolf Juhasz‐Böss, Erich‐Franz Solomayer, Sigrun Smola	43
16	Vol. 33, Issue 11, November 2010 / Band 33, Heft 11, November 2010 2010 ·Onkologie ·(unknown), (unknown), Nadia Harbeck, Mathias Warm, Peter Mallmann, (unknown), Katharina C. Kähler, Thomas Schwarz, Christoph Mundhenke, Axel Hauschild, (unknown), (unknown)	2
17	Impact of tumor biological factors on response to pre-operative epirubicin and paclitaxel chemotherapy in primary breast cancer. 2007 ·PubMed ·Mathias Warm, Ronald Kates, Peter Mallmann, (unknown), Frank Nawroth, Nadia Harbeck, Stefan Paepke, Anke Thomas	7
18	[Breast cancer: adjuvant therapy with trastuzumab: herceptin adjuvant (HERA) Trial Study, B-31- and N9831-Study]. 2006 ·Der Internist ·Peter Mallmann	1
19	Fetal Cord Blood as an Alternative Source of Hematopoietic Progenitor Cells: Immunophenotype, Maternal Cell Contamination, and Ex Vivo Expansion 1999 ·Journal of Hematotherapy ·Heike Engel, Ekrem Kaya, R. Bald, (unknown), (unknown), Thomas Schöndorf, (unknown), Christian M. Kurbacher, U.-J. Göhring, (unknown), Peter Mallmann	5
20	Results of the European multicenter study of radionuclide mammography with Tc-99m-MIBI. 1998 ·PubMed ·F. Grünwald, H. Palmedo, Peter Mallmann, Biersack Hj	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact